Back
Genmab AS Vs. Innodata Industry Stock Comparison
Sell
44
GMAB
Genmab AS
Last Price:
$19.96
Seasonality Move:
10.21%
Buy
57
INOD
Innodata
Last Price:
$43.15
Seasonality Move:
9.95%
Sell
44
Genmab AS (GMAB)
is a Sell
Is Genmab AS a Buy, Sell or Hold?
-
GMAB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GMAB Stock Price Chart
GMAB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.36 | Buy |
Relative Strength Index (14 RSI): | 38.91 | Sell |
Chaikin Money Flow: | -62520 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.76 - 23.22) | Sell |
Bollinger Bands (100): | (20.21 - 22.75) | Sell |
INOD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.98 | Buy |
Relative Strength Index (14 RSI): | 48.16 | Sell |
Chaikin Money Flow: | 2054291 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.81 - 56.89) | Sell |
Bollinger Bands (100): | (27.66 - 49.5) | Buy |
GMAB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.67 | Sell |
20-day SMA: | 22.08 | Sell |
50-day SMA: | 21.22 | Sell |
200-day SMA: | 24.01 | Sell |
8-day EMA: | 22.13 | Sell |
20-day EMA: | 22 | Sell |
50-day EMA: | 21.58 | Sell |
200-day EMA: | 23.91 | Sell |
INOD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.8 | Sell |
20-day SMA: | 51.81 | Sell |
50-day SMA: | 44 | Buy |
200-day SMA: | 27.27 | Buy |
8-day EMA: | 48.42 | Sell |
20-day EMA: | 49.11 | Sell |
50-day EMA: | 45.07 | Buy |
200-day EMA: | 30.62 | Buy |
Genmab AS Earnings Growth & GMAB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $5.18 per share, an increase this year of $0.19 per share, and an increase next year of $0.40 per share.
Innodata Earnings Growth & INOD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.03 per share, and an increase next year of $0.36 per share.
Genmab AS Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Innodata Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |